Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine
Video Credit: ANI - Duration: 01:21s - Published
Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine
Director General of Indian Council of Medical Research, Balram Bhargava on September 15 informed about the COVID-19 vaccines trial stage in India.
He said, Cadila and Bharat Biotech have completed phase-I trials and Serum Institute has completed phase II-B3 trials, and will start phase-III trials after clearance.
He said, "3 vaccines are at clinical trial stage in India.
Cadila and Bharat Biotech have completed phase-I trials.
Serum Institute has completed phase II-B3 trials, and will start phase-III trial (with 1500 patients at 14 locations) after clearances."
![New promising results from Moderna vaccine trial [Video]](https://video.newsserve.net/300/v/20200930/2009301939-New-promising-results-from-Moderna-vaccine-trial.jpg)
![Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister [Video]](https://video.newsserve.net/300/v/20200930/2009301756-Covid-vaccine-Covaxin-phase-trials-on.jpg)
![Moderna and Regeneron Jump on Positive Covid-19 Vaccine Trials [Video]](https://video.newsserve.net/300/v/20200930/2009301314-Moderna-and-Regeneron-Jump-on-Positive-Covid-19.jpg)
